Abstract P17 Table 1
IndicationNumber (n=179)No. +ve IGRA (n=32) (% of group)Treated latent/active TB (n=21) (% of positive IGRA)
Latent TB (n=108)Pre-Anti TNF therapy451 (2%)1 (100%)
Contact screening2911 (38%)5 (45%)
Healthcare worker screening236 (26%)4 (75%)
New entrant114 (36%)2 (50%)
To exclude active TB (n=71)Fever, lymphadenopathy or systemically unwell437 (16%)6 (86%)
Uveitis/choroiditis153 (20%)2 (66%)
HIV infection20 (0%)0 (0%)